Disclaimer: This information is intended for educational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Clinical decisions must always be made by a qualified healthcare professional, taking into account the individual patient's circumstances and current medical guidelines. While this content aims to be comprehensive and evidence-based, medical knowledge evolves, and practices may vary. Always refer to the most current official guidelines and professional judgment.

---

Plantar Fasciitis

Overview

• Definition: Plantar fasciitis (PF) is a common musculoskeletal condition characterized by pain at the bottom of the heel and arch of the foot. Historically considered an inflammatory condition, it is now understood primarily as a degenerative process involving repetitive microtrauma and subsequent collagen degeneration of the plantar fascia origin at its insertion into the medial calcaneal tuberosity, often with reactive bone changes.
• Epidemiology:
  • Prevalence: Affects approximately 10% of the general population over a lifetime.
  • Incidence: Approximately 1 million patient visits per year in the US.
  • Age: Most common in individuals between 40 and 60 years old, though it can occur in younger athletes.
  • Gender: Affects men and women equally in the general population, but may be slightly more common in women in some athletic populations.
  • Occupation: More common in individuals whose occupations require prolonged standing or walking (e.g., factory workers, teachers, healthcare professionals).
• Classification: Plantar fasciitis is generally classified based on its duration and response to treatment:
  • Acute: Symptoms present for less than 6 weeks.
  • Subacute: Symptoms present for 6 weeks to 3 months.
  • Chronic: Symptoms present for more than 3 to 6 months, often associated with more significant degenerative changes.
  • Often associated with a heel spur, which is a common radiographic finding but typically not the primary source of pain.

Pathophysiology

• Mechanism: The plantar fascia is a thick, fibrous aponeurosis extending from the medial calcaneal tuberosity to the proximal phalanges. It supports the longitudinal arch of the foot and acts as a shock absorber. Plantar fasciitis develops from a cycle of repetitive microtrauma, usually from tensile loading, at the fascial origin on the calcaneus. This leads to collagen degeneration, disorganization, and thickening, rather than acute inflammation. Histopathologic studies reveal angiofibroblastic hyperplasia, mucoid degeneration, and absence of inflammatory cells, supporting the 'fasciosis' rather than 'fasciitis' concept.
  • Windlass Mechanism: Impairment of the foot's "windlass mechanism" (tightening of the plantar fascia during dorsiflexion of the toes, elevating the arch) can increase strain.
• Risk Factors:
  • Biomechanical Factors:
    • Pes planus (flat feet): Overpronation during gait increases tensile strain on the fascia.
    • Pes cavus (high arches): Limits natural shock absorption, increasing stress.
    • Tight Achilles tendon/gastroc-soleus complex: Limits ankle dorsiflexion, increasing compensatory strain on the plantar fascia during gait.
    • Leg length discrepancy: Can alter gait mechanics.
  • Lifestyle/Activity Factors:
    • Obesity/Overweight: Increased mechanical load on the plantar fascia. Body Mass Index (BMI) > 30 kg/m² significantly increases risk.
    • Prolonged standing or walking: Especially on hard surfaces.
    • Sudden increase in activity level or intensity: E.g., starting a new running regimen.
    • Inadequate footwear: Poor arch support, worn-out shoes, or shoes without adequate cushioning.
    • Running activities: Especially long-distance running, or running on uneven/hard surfaces.
  • Systemic Factors:
    • Age: Decreased elasticity and resilience of tissues with age.
    • Diabetes mellitus: Increased risk due to impaired tissue healing and neuropathy.
    • Inflammatory arthropathies: (e.g., ankylosing spondylitis, reactive arthritis, psoriatic arthritis, rheumatoid arthritis) can cause enthesitis, including plantar fasciitis.
• Protective Factors:
  • Maintaining a healthy body weight.
  • Wearing supportive footwear with good arch support and cushioning.
  • Regular stretching of the plantar fascia and calf muscles.
  • Gradual progression of exercise intensity and duration.
  • Avoiding prolonged standing on hard surfaces.

Clinical Presentation

Signs and Symptoms

• Cardinal Features:
  • Heel pain: Located at the inferomedial aspect of the heel, typically at the insertion of the plantar fascia into the calcaneus.
  • Post-static dyskinesia: Pain is worst with the first steps in the morning or after a period of rest (e.g., getting up from a chair). Pain often improves with activity but may worsen later in the day with prolonged standing or walking.
  • Pain exacerbated by prolonged standing, walking, or running, especially on hard surfaces.
  • Pain with stair climbing due to increased dorsiflexion and loading.
• Early Signs:
  • Mild morning stiffness and pain that resolves quickly.
  • Discomfort after long walks or runs.
• Advanced Signs:
  • Persistent pain throughout the day, even with rest.
  • Pain that limits daily activities, including walking and exercise.
  • Limping or altered gait to avoid weight-bearing on the painful heel.
• Atypical Presentations:
  • Pain radiating into the arch or toes (less common).
  • Bilateral heel pain (occurs in ~30% of cases).
  • Burning or tingling sensation (suggests nerve entrapment, e.g., tarsal tunnel syndrome, rather than pure PF).
  • Night pain (uncommon; suggests alternative diagnoses like tumor, infection, or nerve compression).

Physical Examination

• Inspection:
  • Observe gait: Patients may walk with a subtle antalgic limp, avoiding full heel strike.
  • Assess foot posture: Look for pes planus (flat arch) or pes cavus (high arch).
  • Check for swelling or erythema: Usually absent; if present, may suggest an inflammatory process, infection, or stress fracture.
  • Assess shoe wear patterns: Excessive wear on the medial heel may indicate overpronation.
• Palpation:
  • Specific tenderness: The most consistent finding is exquisite tenderness to palpation at the medial tubercle of the calcaneus, specifically at the origin of the plantar fascia. Tenderness typically reproduces the patient's pain.
  • Palpate along the course of the plantar fascia into the arch to rule out more diffuse involvement.
  • Palpate the Achilles tendon and calcaneal insertion to rule out Achilles tendinopathy/bursitis.
  • Palpate the posterior heel for signs of Haglund's deformity or retrocalcaneal bursitis.
  • Palpate for trigger points in the calf muscles.
• Special Tests:
  • Ankle Dorsiflexion Range of Motion (ROM): Assess for tight Achilles tendon/gastroc-soleus complex. Restricted ankle dorsiflexion (<10 degrees with knee extended) is a common finding.
  • Windlass Test: Passive dorsiflexion of the toes (especially the great toe). This should tighten the plantar fascia and elevate the medial longitudinal arch. Pain during this maneuver may indicate plantar fasciitis.
  • Tinel's Sign (at tarsal tunnel): Percussion over the posterior tibial nerve in the tarsal tunnel (behind the medial malleolus) can elicit tingling or pain, suggesting tarsal tunnel syndrome, which can mimic or coexist with plantar fasciitis.
  • Neurological Exam: Sensation, motor strength, and reflexes should be assessed to rule out radiculopathy or peripheral neuropathy.

Diagnostic Approach

History Taking

• Key Questions:
  • Location and Quality of Pain: "Where exactly does it hurt?" (medial heel is classic). "Is it sharp, dull, aching?"
  • Timing of Pain: "Is it worse with the first steps in the morning or after rest?" "Does it improve with activity and then worsen later?"
  • Aggravating/Alleviating Factors: "What makes it worse (standing, walking, running, stairs)?" "What makes it better (rest, specific shoes)?"
  • Duration of Symptoms: "How long have you had this pain?"
  • Footwear History: "What type of shoes do you wear for daily activities, work, and exercise? How old are they?"
  • Activity Level: "Have you recently increased your walking, running, or standing?"
  • Medical History: "Do you have a history of diabetes, arthritis, or other medical conditions?"
  • Previous Treatments: "What treatments have you tried, and did they help?"
• Red Flags:
  • Bilateral symptoms or systemic symptoms (fever, chills, weight loss, rash, eye inflammation): May suggest inflammatory arthropathy, systemic disease, or infection.
  • Night pain or pain at rest: Atypical for plantar fasciitis; consider stress fracture, tumor, infection, or nerve entrapment.
  • Neurological symptoms (numbness, tingling, weakness in the foot/ankle): Suggestive of nerve impingement (e.g., tarsal tunnel syndrome, radiculopathy).
  • Acute onset after trauma: Consider stress fracture or acute plantar fascia tear.
  • Lack of typical tenderness at fascial insertion: Suggests alternative diagnosis.

Laboratory Tests

• First-Line: No laboratory tests are routinely required for the diagnosis of typical plantar fasciitis, which is a clinical diagnosis.
• Confirmatory: Not used for confirmation of plantar fasciitis.
• Monitoring: Not used for monitoring plantar fasciitis.
  • Indications for Labs: Consider laboratory evaluation only if an inflammatory or systemic condition is suspected based on atypical presentation (e.g., bilateral pain, inflammatory back pain, diffuse arthralgias, skin lesions, family history):
    • Inflammatory markers: Erythrocyte Sedimentation Rate (ESR), C-Reactive Protein (CRP) – elevated in systemic inflammation.
    • Autoimmune markers: Rheumatoid Factor (RF), anti-cyclic citrullinated peptide (anti-CCP), Human Leukocyte Antigen B27 (HLA-B27) – if seronegative spondyloarthropathy or rheumatoid arthritis is suspected.
    • Blood glucose/HbA1c: To screen for or monitor diabetes.

Imaging

• Recommended: Imaging is generally not required for a typical presentation of plantar fasciitis, as it is a clinical diagnosis.
  • Plain Radiographs (X-rays):
    • Indications: If diagnosis is unclear, to rule out other pathology (e.g., stress fracture, calcaneal tumor, severe degenerative arthritis), or if symptoms are chronic and unresponsive to conservative management.
    • Findings: May show a calcaneal spur (heel spur) at the origin of the plantar fascia (present in 50% of symptomatic and 20% of asymptomatic individuals). Heel spurs are usually an incidental finding and not the direct cause of pain. Radiographs can also show calcification within the plantar fascia or a thickened plantar fascia (though MRI is better for this).
• Advanced:
  • Ultrasound (US):
    • Indications: Increasingly used to confirm diagnosis, especially in chronic cases. It's a dynamic, non-invasive, and cost-effective option.
    • Findings: Thickening of the plantar fascia (>4.0 mm-4.5 mm at the calcaneal insertion, compared to <2.5 mm in asymptomatic individuals), hypoechoic areas within the fascia (consistent with degeneration/edema), or peritendinous edema. Can also assess for fluid collection, enthesophytes, or partial tears.
  • Magnetic Resonance Imaging (MRI):
    • Indications: Reserved for atypical presentations, persistent symptoms unresponsive to conservative therapy, suspected stress fracture, osteomyelitis, nerve entrapment, or space-occupying lesions (e.g., tumor).
    • Findings: Thickening of the plantar fascia, signal changes (T1 hypointensity, T2 hyperintensity) indicating edema and degeneration within the fascia and/or adjacent calcaneus (bone marrow edema). Can identify fascial tears, nerve impingement, or other soft tissue pathologies.
  • Bone Scan: Rarely used; may be indicated if a stress fracture is highly suspected and X-rays are negative, or to rule out infection.

Management

The cornerstone of plantar fasciitis management is conservative treatment. Over 90% of patients improve within 6-12 months with non-operative measures.

Acute Management (Initial Conservative Steps)

• Immediate:
  • Rest/Activity Modification: Reduce activities that aggravate pain (e.g., running, prolonged standing, high-impact sports).
  • Ice Application: Apply ice packs to the heel for 15-20 minutes, 3-4 times daily, especially after activity, to reduce pain and discomfort.
• Stabilization:
  • NSAIDs (Nonsteroidal Anti-inflammatory Drugs): Oral NSAIDs (e.g., ibuprofen 400-600 mg every 6-8 hours, naproxen 250-500 mg twice daily) for a short course (7-14 days) can help manage pain, but their role in addressing the underlying degenerative process is limited. Use cautiously due to potential GI and cardiovascular side effects.
  • Over-the-counter pain relievers: Acetaminophen can be used for pain relief.

Chronic Management

• Non-pharmacological: These are the primary treatments.
  • Stretching Exercises: Crucial for long-term success.
    • Plantar Fascia Stretch: Place toes against a wall, lean forward to stretch the arch. Or, cross one leg over the other, grasp the toes of the affected foot, and pull them back towards the shin until a stretch is felt in the arch. Hold for 30 seconds, repeat 3-5 times, several times a day (especially before the first steps in the morning).
    • Calf Stretches (Gastrocnemius and Soleus): Essential for addressing Achilles tightness. Stand with hands on a wall, one leg back. Lean forward keeping heel down. For gastrocnemius, keep knee straight. For soleus, bend knee slightly. Hold 30 seconds, 3-5 reps, 2-3 times daily.
  • Footwear Modification and Orthotics:
    • Supportive Shoes: Wear shoes with good arch support, cushioning, and a slightly elevated heel to reduce tension on the fascia. Avoid walking barefoot or in flat, unsupportive shoes (e.g., flip-flops) especially on hard surfaces.
    • Off-the-shelf Arch Supports/Orthotics: Semirigid or rigid inserts can support the arch and limit excessive pronation, reducing stress on the fascia. A heel cup or cushion can also provide comfort.
    • Custom Orthotics: May be beneficial for patients with significant biomechanical abnormalities or those unresponsive to over-the-counter options, but evidence for superior efficacy over OTC is mixed.
  • Night Splints: Worn overnight to maintain the ankle in a neutral or slight dorsiflexion position and passively stretch the plantar fascia and Achilles tendon, preventing fascial shortening during sleep. This reduces morning pain. Typically worn for 1-3 months. Various designs (boot-style, dorsal).
  • Physical Therapy (PT): A structured PT program can be highly effective, focusing on stretching, strengthening of intrinsic foot muscles and calf muscles, gait analysis, and manual therapy.
  • Weight Management: Significant weight loss for overweight or obese individuals is strongly recommended to reduce mechanical load.
  • Taping: Low-Dye taping or athletic taping techniques can provide temporary arch support and pain relief.
• Pharmacological:
  • Corticosteroid Injections:
    • Mechanism: Delivers potent anti-inflammatory medication directly to the site of pain.
    • Dosage/Administration: Typically 1-2 mL of a corticosteroid (e.g., triamcinolone 10-40 mg, betamethasone 3-6 mg, methylprednisolone 20-40 mg) mixed with local anesthetic (e.g., lidocaine 1%). Injected under sterile conditions, often guided by ultrasound to ensure accurate placement and avoid fascial rupture.
    • Indications: For persistent, localized pain unresponsive to 4-6 weeks of initial conservative measures.
    • Caution: While providing short-term pain relief, multiple injections (more than 2-3 per year) are generally discouraged due to potential risks:
      • Fat pad atrophy: Leading to increased heel pain.
      • Plantar fascia rupture: Rare but serious complication.
      • Infection.
      • Skin depigmentation.
  • Topical NSAIDs: Creams or gels (e.g., diclofenac gel) can provide localized pain relief with fewer systemic side effects than oral NSAIDs.
• Monitoring:
  • Regular follow-up appointments (e.g., every 4-6 weeks initially) to assess pain levels, functional improvement, adherence to treatment, and adjust management plan.
  • Evaluate progress with activity modification and stretching.
  • Consider imaging only if persistent or atypical symptoms.

Treatment Algorithms (Stepwise Approach)

• First-Line (Initial Conservative Management, ~4-6 weeks):
  1. Activity Modification: Avoid aggravating activities.
  2. Relative Rest: Short periods as needed.
  3. Ice: 15-20 minutes, several times daily.
  4. Stretching: Plantar fascia and calf stretches (multiple times daily, especially before morning weight-bearing).
  5. Supportive Footwear: Avoid barefoot walking, wear cushioned, supportive shoes.
  6. Over-the-counter Orthotics/Arch Supports: Heel cups or semirigid orthotics.
  7. Short course of oral NSAIDs (if pain is significant and no contraindications).
• Second-Line (If no significant improvement after 4-6 weeks of first-line):
  1. Night Splints: Consistent use for 1-3 months.
  2. Physical Therapy Referral: For structured program, gait analysis, manual therapy, strengthening.
  3. Corticosteroid Injection: Targeted injection (often ultrasound-guided) if localized pain is severe and unremitting. Limit to 1-2 injections per year.
  4. Custom Orthotics: Consider if OTC orthotics are insufficient or significant biomechanical issues exist.
  5. Taping: For temporary relief and support.
• Refractory Cases (Symptoms persisting >6-12 months despite comprehensive conservative management):
  1. Extracorporeal Shockwave Therapy (ESWT):
     • Mechanism: Delivers high-energy acoustic waves to the affected tissue, proposed to stimulate healing, angiogenesis, and nerve regeneration.
     • Indications: For chronic plantar fasciitis unresponsive to at least 6 months of conservative treatment.
     • Evidence: Moderate evidence of efficacy for chronic cases, superior to placebo.
     • Dosage: Typically 3-5 sessions, 1-2 weeks apart, with energy levels ranging from low to high.
     • Side Effects: Pain during treatment, transient swelling, numbness, bruising.
  2. Platelet-Rich Plasma (PRP) Injections:
     • Mechanism: Involves injecting concentrated platelets (from patient's own blood) which release growth factors thought to promote tissue healing and regeneration.
     • Evidence: Emerging evidence, some studies show promise, but more high-quality research is needed to determine optimal preparation, dosage, and efficacy compared to other treatments. Not yet a first-line treatment.
  3. Botulinum Toxin A (Botox) Injections:
     • Mechanism: Targets nerve endings to relax specific muscles (e.g., calf muscles) to reduce tension on the plantar fascia. Also thought to have a pain-modulating effect.
     • Evidence: Limited and mixed evidence; not routinely recommended.
  4. Surgery (Plantar Fasciotomy):
     • Indications: Considered only as a last resort for severe, debilitating pain unresponsive to at least 6-12 months (or longer) of aggressive non-operative treatment. Success rates around 70-90%.
     • Procedure: Partial release of the plantar fascia (medial one-third to one-half) from its calcaneal origin, usually endoscopically or open.
     • Risks: Medial arch pain, nerve injury (e.g., lateral plantar nerve entrapment), infection, scarring, prolonged recovery, persistent pain, and potential for iatrogenic arch collapse due to over-release.
     • Post-operative: Non-weight-bearing initially, followed by progressive weight-bearing and rehabilitation.

Complications

• Common:
  • Chronic pain: Persistent pain despite treatment, leading to activity limitation.
  • Recurrence: Symptoms may return, especially if underlying risk factors (e.g., tight calves, poor footwear) are not addressed.
  • Compensatory pain: Pain in other parts of the foot, ankle, knee, hip, or back due to altered gait mechanics.
• Serious (Rare):
  • Plantar fascia rupture: Typically associated with aggressive or multiple corticosteroid injections, or very high-impact activities. Causes acute severe pain, swelling, and bruising, often necessitating prolonged immobilization. Can lead to flattened arch and chronic pain.
  • Nerve injury: Possible with injections (e.g., lateral plantar nerve, medial calcaneal nerve) leading to numbness, tingling, or weakness.
  • Infection: Rare complication of injections or surgery.
  • Stress fracture of the calcaneus: Can be confused with plantar fasciitis or occur concurrently, especially in athletes.
• Long-term:
  • Persistent functional limitation and reduced quality of life if chronic pain is not adequately managed.
  • Alterations in gait leading to secondary musculoskeletal issues.

Prognosis

• Factors:
  • Good Prognostic Factors: Younger age, shorter duration of symptoms (<6 months), absence of obesity, adherence to conservative treatment, early initiation of stretching.
  • Poor Prognostic Factors: Longer duration of symptoms (>12 months), obesity, occupational demands requiring prolonged standing, presence of inflammatory arthropathy.
• Survival: Plantar fasciitis is not a life-threatening condition.
• Quality of Life: Significantly impacts quality of life due to pain, reduced mobility, and inability to participate in desired activities. With appropriate treatment, the vast majority of patients (90-95%) achieve significant improvement or complete resolution of symptoms within 6-12 months. However, a small percentage may experience chronic, refractory pain.

Prevention

• Primary: Preventing initial occurrence.
  • Appropriate Footwear: Wear supportive shoes with good arch support and cushioning for daily activities and exercise. Replace athletic shoes regularly (every 300-500 miles for runners).
  • Regular Stretching: Consistent daily stretching of the plantar fascia and calf muscles, especially if at risk (e.g., runners, those with tight calves).
  • Gradual Increase in Activity: Avoid sudden increases in intensity, duration, or frequency of weight-bearing activities. Follow the "10% rule" (do not increase training by more than 10% per week).
  • Weight Management: Maintain a healthy body weight.
  • Cross-training: Incorporate non-impact activities (e.g., swimming, cycling) to reduce repetitive stress on the feet.
• Secondary: Early detection and intervention.
  • Educate patients about early symptoms and encourage prompt evaluation.
  • Early implementation of conservative measures (stretching, ice, activity modification) to prevent progression to chronic pain.
• Tertiary: Preventing complications or recurrence.
  • Continued adherence to stretching and strengthening programs even after symptoms resolve.
  • Ongoing use of supportive footwear and orthotics as needed.
  • Addressing underlying biomechanical factors.
  • Patient education on identifying and avoiding aggravating activities.

Special Populations

• Pediatric:
  • Rare in pre-pubescent children. When it occurs, may be related to excessive activity, rapid growth spurts, or underlying biomechanical issues.
  • Sever's Disease (Calcaneal Apophysitis): Most common cause of heel pain in children (8-14 years old). It's an inflammation of the growth plate at the back of the heel, not true plantar fasciitis. Pain is typically posterior heel, not plantar. Management involves rest, ice, activity modification, heel cups, and stretching.
  • Consider other diagnoses if suspicion for inflammatory disease is high.
• Geriatric:
  • Increased prevalence due to age-related changes in connective tissue elasticity and strength.
  • May have higher rates of comorbidities (e.g., diabetes, peripheral neuropathy, arthritis) that can influence presentation and healing.
  • Caution with NSAIDs due to increased risk of renal, GI, and cardiovascular side effects.
  • Consider fat pad atrophy, which is more common with age, potentially contributing to heel pain.
  • Emphasis on comfortable, well-cushioned shoes.
• Pregnancy:
  • Increased risk due to weight gain, hormonal changes leading to ligamentous laxity, and altered gait mechanics.
  • Conservative management (stretching, supportive footwear, orthotics, ice) is preferred.
  • Avoid oral NSAIDs, especially in the third trimester due to risks to the fetus (premature closure of ductus arteriosus). Acetaminophen is safer.
  • Corticosteroid injections can be considered if necessary, but generally avoided in the first trimester.
• Comorbidities:
  • Diabetes Mellitus: Patients with diabetes have a higher incidence of plantar fasciitis and may experience delayed healing. Nerve entrapment (tarsal tunnel) is more common. Careful foot care is essential.
  • Inflammatory Arthropathies (e.g., Ankylosing Spondylitis, Psoriatic Arthritis, Reactive Arthritis): Plantar fasciitis can be an initial presentation of enthesitis. If suspicion for systemic inflammatory disease exists (e.g., bilateral involvement, morning stiffness >30 minutes, inflammatory back pain, skin/eye involvement), a rheumatology referral and appropriate lab tests (ESR, CRP, HLA-B27) are warranted. Management may involve DMARDs in addition to local measures.

Clinical Pearls

• Diagnostic:
  • The classic history of first-step morning pain is highly suggestive of plantar fasciitis.
  • Pinpoint tenderness at the medial calcaneal tubercle is the most reliable physical exam finding.
  • Do not confuse heel spurs on X-ray with the cause of pain; they are typically an incidental finding.
  • Always assess ankle dorsiflexion; calf tightness is a key contributing factor.
  • Consider alternative diagnoses (stress fracture, nerve entrapment, fat pad atrophy, inflammatory arthropathy) if the presentation is atypical or fails to respond to initial conservative therapy.
• Treatment:
  • Consistency is key: Daily stretching and activity modification are more important than any single intervention.
  • Conservative treatment works: Over 90% of patients improve within 6-12 months. Patience and adherence are crucial.
  • Night splints are highly effective for morning pain, but require consistent use.
  • Corticosteroid injections provide temporary relief but do not address the underlying pathology and carry risks with repeated use. Use sparingly.
  • Surgery is a last resort after extensive failed conservative management (at least 6-12 months).
• Pitfalls:
  • Over-reliance on imaging: Often unnecessary and can lead to misinterpretation (e.g., incidental heel spur).
  • Ignoring calf tightness: Failure to address tight gastrocnemius and soleus muscles through stretching.
  • Poor footwear choices: Allowing patients to continue wearing unsupportive shoes, especially barefoot walking on hard surfaces.
  • Too many injections: Leading to complications like fat pad atrophy or fascial rupture.
  • Premature surgical referral: Before exhausting all reasonable conservative options.
  • Failure to educate patients: Explaining the chronic degenerative nature of the condition and the importance of long-term self-management.

Recent Updates

• Guidelines:
  • The American Academy of Orthopaedic Surgeons (AAOS) provides clinical practice guidelines, consistently emphasizing conservative management as first-line treatment.
  • Current guidelines support the strong recommendation for stretching, night splints, and arch supports.
  • Recommendations for ESWT are typically for chronic cases refractory to 6 months of other conservative care.
• Evidence:
  • Increasing evidence supports the concept of plantar fasciitis as a degenerative rather than purely inflammatory condition (fasciosis).
  • While corticosteroids provide short-term relief, their long-term benefit is debated, and risks of fascial rupture are well-documented. Ultrasound guidance for injections is becoming standard practice to improve accuracy and reduce complications.
  • Growing interest in biologic injections (PRP, stem cells) but current evidence for superiority over established treatments is inconclusive, and they are not yet standard of care.
  • Surgical intervention remains reserved for very refractory cases.
• Controversies:
  • Optimal dosage and frequency for ESWT and PRP: Still under investigation.
  • Role of dry needling: Some evidence suggests benefit, particularly for trigger points in the calf or plantar fascia itself, but not universally adopted.
  • Necessity of custom orthotics over off-the-shelf: Clinical trials often show similar efficacy, but patient-specific biomechanics may warrant custom.

Key References

• Guidelines:
  • Thomas JL, et al. The American Academy of Orthopaedic Surgeons Evidence-Based Clinical Practice Guideline on the Treatment of Plantar Fasciitis. J Bone Joint Surg Am. 2010;92(14):2477-2489. (Note: While 2010, foundational. Regular updates/reviews should be consulted.)
  • Riddle DL, et al. Heel pain—plantar fasciitis: revision 2014. J Orthop Sports Phys Ther. 2014;44(11):A1-A33. (Clinical Practice Guideline from Orthopaedic Section of the American Physical Therapy Association).
• Studies:
  • Landorf KB, et al. Effectiveness of Foot Orthoses to Treat Plantar Fasciitis: A Randomized Trial. Arch Intern Med. 2006;166(12):1305-1310. (Landmark study on orthotics).
  • Crawford F, et al. Steroid injection for plantar fasciitis: a systematic review and meta-analysis. Clin J Sport Med. 2003;13(4):246-248. (Meta-analysis on steroid injections).
  • Goff JD, Crawford R. Diagnosis and Treatment of Plantar Fasciitis: A Concise Review. Curr Rev Musculoskelet Med. 2011;4(3):198-203.
  • Ryan MB, et al. The Efficacy of Platelet-Rich Plasma in the Treatment of Plantar Fasciitis: A Systematic Review. Foot Ankle Int. 2020;41(1):103-113. (Review of PRP evidence).
• Reviews:
  • Karlsson J, et al. Plantar fasciitis: a review of current treatments. Curr Opin Orthop. 2007;18(1):63-67.
  • Young CC, et al. Plantar Fasciitis. Medscape Drugs & Diseases. Updated regularly. (A good comprehensive online resource for clinicians).